Literature DB >> 17399639

Kir2.3 isoform confers pH sensitivity to heteromeric Kir2.1/Kir2.3 channels in HEK293 cells.

Viviana Muñoz1, Ravi Vaidyanathan, Elena G Tolkacheva, Amit S Dhamoon, Steven M Taffet, Justus M B Anumonwo.   

Abstract

BACKGROUND: Data on pH regulation of the cardiac potassium current I(K1) suggest species-dependent differences in the molecular composition of the underlying Kir2 channel proteins.
OBJECTIVE: The purpose of this study was to test the hypothesis that the presence of the Kir2.3 isoform in heterotetrameric channels modifies channel sensitivity to pH.
METHODS: Voltage clamp was performed on HEK293 cells stably expressing guinea pig Kir2.1 and/or Kir2.3 isoforms and on sheep cardiac ventricular myocytes at varying extracellular pH (pH(o)) and in the presence of CO(2) to determine the sensitivity of macroscopic currents to pH. Single-channel activity was recorded from the HEK293 stables to determine the mechanisms of the changes in whole cell current.
RESULTS: Biophysical characteristics of whole-cell and single-channel currents in Kir2.1/Kir2.3 double stables displayed properties attributable to isoform heteromerization. Whole-cell Kir2.1/Kir2.3 currents rectified in a manner reminiscent of Kir2.1 but were significantly inhibited by extracellular acidification in the physiologic range (pK(a) approximately 7.4). Whole-cell currents were more sensitive to a combined extracellular and intracellular acidification produced by CO(2). At pH(o) = 6.0, unitary conductances of heteromeric channels were reduced. Ovine cardiac ventricular cell I(K1) was pH(o) and CO(2) sensitive, consistent with the expression of Kir2.1 and Kir2.3 in this species.
CONCLUSION: Kir2.1 and Kir2.3 isoforms form heteromeric channels in HEK293. The presence of Kir2.3 subunit(s) in heteromeric channels confers pH sensitivity to the channels. The single and double stable cells presented in this study are useful models for studying physiologic regulation of heteromeric Kir2 channels in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17399639      PMCID: PMC1987370          DOI: 10.1016/j.hrthm.2006.12.033

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  31 in total

Review 1.  Inward rectifiers in the heart: an update on I(K1).

Authors:  A N Lopatin; C G Nichols
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  Gating of inward rectifier K+ channels by proton-mediated interactions of N- and C-terminal domains.

Authors:  Z Qu; Z Yang; N Cui; G Zhu; C Liu; H Xu; S Chanchevalap; W Shen; J Wu; Y Li; C Jiang
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

3.  In vivo formation of a proton-sensitive K+ channel by heteromeric subunit assembly of Kir5.1 with Kir4.1.

Authors:  M Tanemoto; N Kittaka; A Inanobe; Y Kurachi
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

4.  The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes.

Authors:  J J Zaritsky; J B Redell; B L Tempel; T L Schwarz
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

5.  Rectification of the background potassium current: a determinant of rotor dynamics in ventricular fibrillation.

Authors:  F H Samie; O Berenfeld; J Anumonwo; S F Mironov; S Udassi; J Beaumont; S Taffet; A M Pertsov; J Jalife
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

6.  Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.

Authors:  N M Plaster; R Tawil; M Tristani-Firouzi; S Canún; S Bendahhou; A Tsunoda; M R Donaldson; S T Iannaccone; E Brunt; R Barohn; J Clark; F Deymeer; A L George; F A Fish; A Hahn; A Nitu; C Ozdemir; P Serdaroglu; S H Subramony; G Wolfe; Y H Fu; L J Ptácek
Journal:  Cell       Date:  2001-05-18       Impact factor: 41.582

7.  Comparison of cloned Kir2 channels with native inward rectifier K+ channels from guinea-pig cardiomyocytes.

Authors:  G X Liu; C Derst; G Schlichthörl; S Heinen; G Seebohm; A Brüggemann; W Kummer; R W Veh; J Daut; R Preisig-Müller
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

8.  Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents.

Authors:  Gernot Schram; Marc Pourrier; Zhiguo Wang; Michel White; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2003-08-01       Impact factor: 10.787

9.  Biophysical and molecular mechanisms underlying the modulation of heteromeric Kir4.1-Kir5.1 channels by CO2 and pH.

Authors:  Z Yang; H Xu; N Cui; Z Qu; S Chanchevalap; W Shen; C Jiang
Journal:  J Gen Physiol       Date:  2000-07-01       Impact factor: 4.086

10.  A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.

Authors:  Silvia G Priori; Sandeep V Pandit; Ilaria Rivolta; Omer Berenfeld; Elena Ronchetti; Amit Dhamoon; Carlo Napolitano; Justus Anumonwo; Marina Raffaele di Barletta; Smitha Gudapakkam; Giuliano Bosi; Marco Stramba-Badiale; José Jalife
Journal:  Circ Res       Date:  2005-03-10       Impact factor: 17.367

View more
  11 in total

1.  Regulation of cardiac inward rectifier potassium current (I(K1)) by synapse-associated protein-97.

Authors:  Ravi Vaidyanathan; Steven M Taffet; Karen L Vikstrom; Justus M B Anumonwo
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Functional consequences of Kir2.1/Kir2.2 subunit heteromerization.

Authors:  Brian K Panama; Meredith McLerie; Anatoli N Lopatin
Journal:  Pflugers Arch       Date:  2010-07-30       Impact factor: 3.657

3.  Strain differences in pH-sensitive K+ channel-expressing cells in chemosensory and nonchemosensory brain stem nuclei.

Authors:  Paul F Martino; S Olesiak; D Batuuka; D Riley; S Neumueller; H V Forster; M R Hodges
Journal:  J Appl Physiol (1985)       Date:  2014-08-21

4.  Epidermal growth factor receptor tyrosine kinase regulates the human inward rectifier potassium K(IR)2.3 channel, stably expressed in HEK 293 cells.

Authors:  De-Yong Zhang; Yan-Hui Zhang; Hai-Ying Sun; Chu-Pak Lau; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

5.  RXP-E: a connexin43-binding peptide that prevents action potential propagation block.

Authors:  Rebecca Lewandowski; Kristina Procida; Ravi Vaidyanathan; Wanda Coombs; José Jalife; Morten S Nielsen; Steven M Taffet; Mario Delmar
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

Review 6.  Cardiac strong inward rectifier potassium channels.

Authors:  Justus M B Anumonwo; Anatoli N Lopatin
Journal:  J Mol Cell Cardiol       Date:  2009-08-22       Impact factor: 5.000

7.  SAP97 regulates Kir2.3 channels by multiple mechanisms.

Authors:  Karen L Vikstrom; Ravi Vaidyanathan; Susan Levinsohn; Ryan P O'Connell; Yueming Qian; Mark Crye; Jeffrey H Mills; Justus M B Anumonwo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-24       Impact factor: 4.733

8.  Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk.

Authors:  Hassan Musa; Cherisse A Marcou; Todd J Herron; Michael A Makara; David J Tester; Ryan P O'Connell; Brad Rosinski; Guadalupe Guerrero-Serna; Michelle L Milstein; André Monteiro da Rocha; Dan Ye; Lia Crotti; Vladislav V Nesterenko; Silvia Castelletti; Margherita Torchio; Maria-Christina Kotta; Federica Dagradi; Charles Antzelevitch; Peter J Mohler; Peter J Schwartz; Michael J Ackerman; Justus M Anumonwo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-20       Impact factor: 4.733

9.  A single-cell model of phase-driven control of ventricular fibrillation frequency.

Authors:  Krzysztof R Grzeda; Justus M B Anumonwo; Ryan O'Connell; José Jalife
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

10.  Pregnenolone sulfate potentiates the inwardly rectifying K channel Kir2.3.

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.